Research ArticleClinical Studies
Risk Factors for Sleep Disturbances in Patients Scheduled for Radiotherapy of Head-and-Neck Cancer
DIRK RADES, SVENJA KOPELKE, TAMER SOROR, TOBIAS BARTSCHT, SOEREN TVILSTED, TROELS W. KJAER and STEVEN E. SCHILD
Anticancer Research October 2021, 41 (10) 5065-5069; DOI: https://doi.org/10.21873/anticanres.15322
DIRK RADES
1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany;
SVENJA KOPELKE
1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany;
2Department of Hematology and Oncology, University of Lübeck, Lübeck, Germany;
TAMER SOROR
1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany;
TOBIAS BARTSCHT
2Department of Hematology and Oncology, University of Lübeck, Lübeck, Germany;
SOEREN TVILSTED
3Research Projects and Clinical Optimization, Zealand University Hospital, Koege, Denmark;
TROELS W. KJAER
4Department of Neurology, Zealand University Hospital, Roskilde, Denmark;
STEVEN E. SCHILD
5Department of Radiation Oncology, Mayo Clinic, Scottsdale, AZ, U.S.A.
In this issue
Anticancer Research
Vol. 41, Issue 10
October 2021
Risk Factors for Sleep Disturbances in Patients Scheduled for Radiotherapy of Head-and-Neck Cancer
DIRK RADES, SVENJA KOPELKE, TAMER SOROR, TOBIAS BARTSCHT, SOEREN TVILSTED, TROELS W. KJAER, STEVEN E. SCHILD
Anticancer Research Oct 2021, 41 (10) 5065-5069; DOI: 10.21873/anticanres.15322
Jump to section
Related Articles
- No related articles found.
Cited By...
- Development of Distress During a Radiotherapy Course for Head-and-neck Cancer
- Emotional Distress in Head-and-neck Cancer Patients Scheduled for Chemoradiation or Radiotherapy Alone
- Distress Scores During a Course of Radiotherapy: A Pilot Study
- Evaluation of Sleep Disturbances in Patients With Bladder Cancer Scheduled for Local or Loco-regional Radiochemotherapy
- Improvement of Sleep Disorders During a Course of Radiotherapy for Breast Cancer - Final Results of the Prospective Interventional RADIO-SLEEP Trial
- Risk Factors for Sleep Problems Prior to Radiochemotherapy for Malignant Gliomas